Core Viewpoint - Centene (CNC) reported quarterly earnings of $0.5 per share, significantly exceeding the Zacks Consensus Estimate of a loss of $0.21 per share, marking an earnings surprise of +338.10% [1] - The company generated revenues of $49.69 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 4.35% and showing an increase from $42.02 billion year-over-year [2] Financial Performance - Centene's earnings for the previous year were $1.62 per share, indicating a decline in profitability [1] - The company has surpassed consensus EPS estimates three times over the last four quarters [2] - The current consensus EPS estimate for the upcoming quarter is -$0.87, with projected revenues of $47.41 billion, while the estimate for the current fiscal year is $1.69 on $190.45 billion in revenues [7] Market Position - Centene shares have underperformed, losing about 45.2% since the beginning of the year, compared to a 17.2% gain in the S&P 500 [3] - The Zacks Rank for Centene is currently 5 (Strong Sell), indicating expectations of underperformance in the near future [6] Industry Outlook - The Medical - HMOs industry, to which Centene belongs, is currently ranked in the bottom 26% of over 250 Zacks industries, suggesting a challenging environment [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Centene's stock performance [5]
Centene (CNC) Surpasses Q3 Earnings and Revenue Estimates